Related Experiment Video

Updated: Jul 22, 2025

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

1.0K

Using CRISPR/Cas9 to Edit a Thyroid Cancer Cell Line

Cesar Seigi Fuziwara1, Edna Teruko Kimura2

  • 1Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.

Advances in Experimental Medicine and Biology
|July 24, 2023
PubMed

Insights

Thyroid cancer, the most common endocrine cancer, involves genetic changes in MAPK signaling. Researchers are using CRISPR/Cas9 gene-editing technology to study thyroid cancer cell lines and understand its biology.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid cancer is the most common endocrine malignancy, characterized by diverse subtypes and distinct clinical-pathological features.
  • Oncogenesis is linked to genetic alterations in MAPK signaling pathways, affecting cell proliferation and noncoding gene expression (microRNAs, long noncoding RNAs).

Purpose of the Study:

  • To explore the application of CRISPR/Cas9 technology in investigating thyroid cancer biology.
  • To review current in vitro studies utilizing CRISPR/Cas9 in thyroid cancer research.

Main Methods:

  • CRISPR/Cas9 gene-editing system.
  • In vitro studies on thyroid cancer cell lines.
  • Analysis of gene sequence modification and gene expression modulation.

Main Results:

  • CRISPR/Cas9 enables precise gene editing in thyroid cancer cells.
  • The technology facilitates the study of gene functions in thyroid cancer development.
  • Modulation of noncoding RNAs and MAPK signaling pathways can be investigated.

Conclusions:

  • CRISPR/Cas9 is a valuable tool for advancing thyroid cancer research.
  • In vitro applications of CRISPR/Cas9 are crucial for understanding thyroid cancer biology.
  • Further research using CRISPR/Cas9 may lead to novel therapeutic strategies.

More Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

13.2K
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

11.3K

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
64
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K